All the problems within management have been resolved a while ago, Steve Kubby is not involved in any way with CBIS. CBIS has generated new income streams with RockBrook, a contract has been signed and it benefits CBIS right now and in the long term. CBIS law team is also taking legal actions against Montana Pain Management for breaching the contract, this case could make CBIS some good cash. They do not have too much liability, the market for this particular stock is so big that it won't even matter (in the billions of $'s) they are receiving and raising funds for the FDA trials. They have an EXTREMELY SAFE AND SMART plan to approaching the FDA trials. Right now they are treating patients for profit and nonprofit, only to use the data as scientific evidence for the FDA trials. The main diseases CBIS wants to make cures for is PTSD and Chronic Pain management. Think about this you guys, this stock was trading in the $0.20 - $0.62 range in the past few months and their was no hype or momentum building then. But now since the FDA trials, the dividend news, and the Prop 19 are approaching their is NOTHING stopping this. This is an extremely strong buy, in my perspective
